2020
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
Magbanua MJM, Hendrix LH, Hyslop T, Barry WT, Winer EP, Hudis C, Toppmeyer D, Carey LA, Partridge AH, Pierga JY, Fehm T, Vidal-Martínez J, Mavroudis D, Garcia-Saenz JA, Stebbing J, Gazzaniga P, Manso L, Zamarchi R, Antelo ML, De Mattos-Arruda L, Generali D, Caldas C, Munzone E, Dirix L, Delson AL, Burstein HJ, Qadir M, Ma C, Scott JH, Bidard FC, Park JW, Rugo HS. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy. Journal Of The National Cancer Institute 2020, 113: 443-452. PMID: 32770247, PMCID: PMC8023821, DOI: 10.1093/jnci/djaa113.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsFemaleHumansNeoplastic Cells, CirculatingPrognosisProgression-Free SurvivalProportional Hazards ModelsReproducibility of ResultsRetrospective StudiesTreatment OutcomeConceptsProgression-free survivalFirst-line chemotherapyOverall survivalBaseline CTCsCTC statusPrognostic groupsInferior progression-free survivalMetastatic breast cancer patientsFuture prospective clinical trialsNovel prognostic groupsMetastatic breast cancerProspective clinical trialsRisk stratification strategiesBreast cancer patientsCourse of treatmentMore effective treatmentsUndetectable CTCsMBC patientsHazard ratioPoor outcomePrognostic significanceCox regressionCancer patientsClinical trialsCTC measurement
2005
Cancer‐related communication between female patients and male partners scale: a pilot study
Kornblith AB, Regan MM, Kim Y, Greer G, Parker B, Bennett S, Winer E. Cancer‐related communication between female patients and male partners scale: a pilot study. Psycho-Oncology 2005, 15: 780-794. PMID: 16308887, DOI: 10.1002/pon.1004.Peer-Reviewed Original ResearchConceptsFemale patientsMale partnersTreatment-specific issuesFemale cancer patientsInternal consistencyCancer-related communicationCancer patientsHospital AnxietyDepression ScalePatientsProtective bufferingPilot studyItem scaleSociety websitesStudy objectiveY-MeDyadic Adjustment ScaleCancerCouples ScaleEmotional supportAdjustment ScaleHADSScale reliabilityLack of clarityAssessment of a Dietary Questionnaire in Cancer Patients Receiving Cytotoxic Chemotherapy
Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS. Assessment of a Dietary Questionnaire in Cancer Patients Receiving Cytotoxic Chemotherapy. Journal Of Clinical Oncology 2005, 23: 8453-8460. PMID: 16293876, DOI: 10.1200/jco.2005.02.5460.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic AgentsBiomarkersBreast NeoplasmsCarotenoidsColorectal NeoplasmsFatty AcidsFeeding BehaviorFemaleHumansMaleMiddle AgedMultivariate AnalysisNeuroendocrine TumorsNutrition AssessmentNutrition SurveysReproducibility of ResultsSurveys and QuestionnairesTocopherolsConceptsDietary questionnaireCytotoxic chemotherapyCancer patientsPlasma specimensInfluence of dietHealthy populationTotal vitamin E intakeSemiquantitative food frequency questionnaireComprehensive dietary questionnairesFood frequency questionnaireVitamin E intakeBody mass indexTotal energy intakeTotal plasma cholesterolChemotherapy-associated toxicitySelf-reported dietFrequency questionnaireE intakeMass indexSmoking statusNeuroendocrine cancerDietary factorsDietary intakePlasma cholesterolPatients
2000
Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique.
Hellmann K, Hensley M, Schuchter L, Winer E, Meropol N, Pfister D. Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique. Journal Of Clinical Oncology 2000, 18: 2004-6. PMID: 10784645, DOI: 10.1200/jco.2000.18.9.2004.Peer-Reviewed Original Research